期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CANCER BIOLOGY & THERAPY LetPub Score 6.4
51 ratings
Rate
Reputation 7.5 Influence 5.3 Speed 6.9 | ||||||||||||||||||||||||||||
期刊簡稱 | CANCER BIOL THER | ||||||||||||||||||||||||||||
ISSN | 1538-4047 | ||||||||||||||||||||||||||||
E-ISSN | 1555-8576 | ||||||||||||||||||||||||||||
h-index | 101 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://www.tandfonline.com/loi/kcbt20#.V4he8kz9cSQ | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CBT | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Landes Bioscience | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||||||
每年文章數 | 81每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 79.27% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4047%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2.3 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CANCER BIOLOGY & THERAPY] 的評論 | 撰寫評論 |
作者: jinglepph 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-10 22:36:03 評論於 May I ask if withdrawing a submission requires writing directly to the editor or withdrawing it through the system? Do I need to wait for a response from the editorial department before resubmitting?(0) 讚! | jinglepph |
作者: DreamCar 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-30 12:37:29 評論於 A very trashy magazine, took 6 months for the first review, and had to keep urging for minor revisions. After the revisions, there was no news for 14 months. They didn't reply to emails, so I withdrew the submission without waiting any longer. It was too much of a delay. I suggest that students should not submit to this magazine, it's a huge disappointment!!!(0) 讚! | DreamCar |
作者: 木子 領域: 医学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2020-08-10 19:09:33 評論於 After waiting for five months, it was directly rejected, without being sent for external review. I hope it can still be processed as soon as possible in the future. (0) 讚! | 木子 |
作者: 木木 領域: 医学 審稿時間: 8.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-24 08:52:42 評論於 It was with editor for 4 months before being sent for review. It has been reviewed for 4 months, but there is no news. Be careful to submit if you are anxious to graduate. the editorial office is estimated to be fighting the pandemic recently, and it is no longer 2 or 3 months as said. (5) 讚! | 木木 |
作者: 被逼无奈搞科研 領域: 医学 審稿時間: 6.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-17 17:01:43 評論於 There is no news received for more than a month, after being received by journal. It is so disappointing. (0) 讚! | 被逼无奈搞科研 |
作者: Parry 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-01-18 17:53:05 評論於 Although this is not a top journal in the field, I am very excited about my recent submission. Have people had good experiences with publishing in this journal? (2) 讚! | Parry |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us